|
No Time to Waste: Real-World Repurposing of Generic Drugs as a Multifaceted Strategy Against COVID-19
JMIRx Med 2020;1(1):e19583
Go back to the top of the top articles page
Skip top articles and go to footer section
| 1005 | 8 | 1 | |
|
A Machine Learning Explanation of the Pathogen-Immune Relationship of SARS-CoV-2 (COVID-19), and a Model to Predict Immunity and Therapeutic Opportunity: A Comparative Effectiveness Research Study
JMIRx Med 2020;1(1):e23582
Go back to the top of the top articles page
Skip top articles and go to footer section
| 782 | 58 | 0 | |
|
Peer Review of “No Time to Waste: Real-World Repurposing of Generic Drugs as a Multifaceted Strategy Against COVID-19”
JMIRx Med 2020;1(1):e24453
Go back to the top of the top articles page
Skip top articles and go to footer section
| 186 | 0 | 0 | |
|
Authors’ Response to Peer Reviews of “No Time to Waste: Real-World Repurposing of Generic Drugs as a Multifaceted Strategy Against COVID-19”
JMIRx Med 2020;1(1):e24485
Go back to the top of the top articles page
Skip top articles and go to footer section
| 186 | 0 | 0 | |
|
Peer Review of “No Time to Waste: Real-World Repurposing of Generic Drugs as a Multifaceted Strategy Against COVID-19”
JMIRx Med 2020;1(1):e24481
Go back to the top of the top articles page
Skip top articles and go to footer section
| 152 | 0 | 0 | |
|
Peer Review of “A Machine Learning Explanation of the Pathogen-Immune Relationship of SARS-CoV-2 (COVID-19), and a Model to Predict Immunity and Therapeutic Opportunity: A Comparative Effectiveness Research Study”
JMIRx Med 2020;1(1):e24747
Go back to the top of the top articles page
Skip top articles and go to footer section
| 90 | 1 | 0 | |
|
Predicting Health Disparities in Regions at Risk of Severe Illness to Inform Health Care Resource Allocation During Pandemics: Observational Study
JMIRx Med 2020;1(1):e22470
Go back to the top of the top articles page
Skip top articles and go to footer section
| 88 | 2 | 2 | |
|
Author Response to Peer Reviews of “A Machine Learning Explanation of the Pathogen-Immune Relationship of SARS-CoV-2 (COVID-19), and a Model to Predict Immunity and Therapeutic Opportunity: A Comparative Effectiveness Research Study”
JMIRx Med 2020;1(1):e24739
Go back to the top of the top articles page
Skip top articles and go to footer section
| 68 | 1 | 0 | |
|
Peer Review of “A Machine Learning Explanation of the Pathogen-Immune Relationship of SARS-CoV-2 (COVID-19), and a Model to Predict Immunity and Therapeutic Opportunity: A Comparative Effectiveness Research Study”
JMIRx Med 2020;1(1):e24765
Go back to the top of the top articles page
Skip top articles and go to footer section
| 64 | 1 | 0 | |
|
Evaluating Population Density as a Parameter for Optimizing COVID-19 Testing: Statistical Analysis
JMIRx Med 2021;2(1):e22195
Go back to the top of the top articles page
Skip top articles and go to footer section
| 59 | 8 | 3 | |
|
Author’s Response to Peer Review of “Predicting Health Disparities in Regions at Risk of Severe Illness to Inform Health Care Resource Allocation During Pandemics: Observational Study”
JMIRx Med 2020;1(1):e25573
Go back to the top of the top articles page
Skip top articles and go to footer section
| 53 | 1 | 0 | |
|
Peer Review of “Predicting Health Disparities in Regions at Risk of Severe Illness to Inform Health Care Resource Allocation During Pandemics: Observational Study”
JMIRx Med 2020;1(1):e25572
Go back to the top of the top articles page
Skip top articles and go to footer section
| 43 | 1 | 0 | |
|
Authors’ Response to Peer Reviews of “Evaluating Population Density as a Parameter for Optimizing COVID-19 Testing: Statistical Analysis”
JMIRx Med 2021;2(1):e27258
Go back to the top of the top articles page
Skip top articles and go to footer section
| 32 | 1 | 0 | |
|
Peer Review of “Evaluating Population Density as a Parameter for Optimizing COVID-19 Testing: Statistical Analysis”
JMIRx Med 2021;2(1):e27103
Go back to the top of the top articles page
Skip top articles and go to footer section
| 22 | 1 | 1 | |
|
Peer Review of “Evaluating Population Density as a Parameter for Optimizing COVID-19 Testing: Statistical Analysis”
JMIRx Med 2021;2(1):e27257
Go back to the top of the top articles page
Skip top articles and go to footer section
| 18 | 1 | 1 | |
|
A Framework for a Statistical Characterization of Epidemic Cycles: COVID-19 Case Study
JMIRx Med 2021;2(1):e22617
Go back to the top of the top articles page
Skip top articles and go to footer section
| 4 | 3 | 3 | |
|
Peer Review of “A Framework for a Statistical Characterization of Epidemic Cycles: COVID-19 Case Study”
JMIRx Med 2021;2(1):e27536
Go back to the top of the top articles page
Skip top articles and go to footer section
| 3 | 1 | 1 | |
|
Peer Review of “A Framework for a Statistical Characterization of Epidemic Cycles: COVID-19 Case Study”
JMIRx Med 2021;2(1):e27260
Go back to the top of the top articles page
Skip top articles and go to footer section
| 3 | 1 | 1 | |
|
Selection of the Optimal L-asparaginase II Against Acute Lymphoblastic Leukemia: An In Silico Approach
JMIRx Med 2021;2(3):e29844
Go back to the top of the top articles page
Skip top articles and go to footer section
| 0 | 5 | 0 | |
|
Peer Review of “Use of Spinal Anesthesia in Pediatric Laparoscopic Appendectomies: Case Series”
JMIRx Med 2021;2(2):e29605
Go back to the top of the top articles page
Skip top articles and go to footer section
| 0 | 1 | 1 | |
|
Peer Review of “COVID-19 and Cybersecurity: Finally, an Opportunity to Disrupt?”
JMIRx Med 2021;2(2):e29414
Go back to the top of the top articles page
Skip top articles and go to footer section
| 0 | 1 | 1 | |
|
Peer Review of “Machine Learning for Risk Group Identification and User Data Collection in a Herpes Simplex Virus Patient Registry: Algorithm Development and Validation Study”
JMIRx Med 2021;2(2):e28922
Go back to the top of the top articles page
Skip top articles and go to footer section
| 0 | 3 | 0 | |
|
Author’s Responses to Peer Reviews of “Forecasting the COVID-19 Pandemic in Saudi Arabia Using a Modified Singular Spectrum Analysis Approach: Model Development and Data Analysis”
JMIRx Med 2021;2(1):e28742
Go back to the top of the top articles page
Skip top articles and go to footer section
| 0 | 2 | 0 | |
|
Peer Review of “Impact of COVID-19 Testing Strategies and Lockdowns on Disease Management Across Europe, South America, and the United States: Analysis Using Skew-Normal Distributions”
JMIRx Med 2021;2(2):e28681
Go back to the top of the top articles page
Skip top articles and go to footer section
| 0 | 1 | 1 | |
|
Offenders With Personality Disorder Who Fail to Progress: A Case-Control Study Using Partial Least Squares Structural Equation Modeling Path Analysis
JMIRx Med 2021;2(4):e27907
Go back to the top of the top articles page
Skip top articles and go to footer section
| 0 | 9 | 0 | |